Gratitude Expressed for Life Sciences Analysis
July is expected to be a slow month for regulatory actions, with only a small number of FDA-hosted and industry-hosted meetings scheduled. There are also not many legislative or user fee-driven deadlines for the FDA to meet. However, when the FDA released its updated Unified Agenda in June, it listed several regulations that it expected […]